Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06681818 · ClinicalTrials.gov registry record · NA
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
A NA study of Liver Cancer, Adult and Liver Regeneration, sponsored by Englewood Hospital and Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT06681818 is a NA study of Liver Cancer, Adult and Liver Regeneration that is actively recruiting participants, run by Englewood Hospital and Medical Center. The registered enrollment target is 125 participants, above the 50-participant average among 3 other Liver Cancer, Adult trials with a reported enrollment target (150% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06681818, a NA study of Liver Cancer, Adult and Liver Regeneration, is actively recruiting participants, sponsored by Englewood Hospital and Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
Conditions Studied
Interventions
- OTHER carbon monoxide measurement via smokerlyzer
Study Locations (1)
New Jersey
- Englewood Hospital - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2039-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06681818
The ClinicalTrials.gov registry entry for NCT06681818 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 50-participant average among 3 other Liver Cancer, Adult trials with a reported enrollment target (150% higher). The listed sponsor is Englewood Hospital and Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Liver Cancer, Adult appearing as the primary indexed condition, and to 1 intervention - of which carbon monoxide measurement via smokerlyzer is the first listed.
NCT06681818 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06681818 about?
NCT06681818 is a clinical study titled "Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy". the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to t...
What is the current status of trial NCT06681818?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-11-21. Estimated completion is 2039-01-01.
What conditions does trial NCT06681818 study?
This clinical trial studies the following conditions: Liver Cancer, Adult, Liver Regeneration.
What interventions are being tested in trial NCT06681818?
The interventions under investigation include: carbon monoxide measurement via smokerlyzer (OTHER).
Who is sponsoring clinical trial NCT06681818?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06681818 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.